Compass Therapeutics (CMPX) Balance Sheet: Assets & Liabilities

Compass Therapeutics (CMPX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Compass Therapeutics reported total assets of $219.59M and total liabilities of $22.80M. Shareholders' equity was $196.79M, up 57.1% from $125.23M a year earlier. Total debt stood at $9.83M against $208.91M in cash and short-term investments, a net cash position of $199.08M. That puts debt-to-equity at 0.05, compared with 0.05 a year earlier.

Compass Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Compass Therapeutics, Inc. (CMPX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Mar 2020	Mar 2019
Current Assets
Cash and Cash Equivalents	30.64	43.48	24.23	34.95	144.51	47.08	25.30	57.51
Short-Term Investments	178.26	83.24	128.23	151.66	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	208.91	126.72	152.46	186.61	144.51	47.08	25.30	57.51
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.91	6.03	1.42	8.18	2.59	3.13	0.94	1.37
Total Current Assets	209.82	132.75	153.88	194.79	147.11	50.20	26.24	58.88
Non-Current Assets
Property, Plant & Equipment (Net)	9.20	7.08	2.67	4.53	6.33	1.13	3.75	5.37
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.26
Other Non-Current Assets	0.57	0.57	0.32	0.32	0.32	0.58	0.39	0.12
Total Non-Current Assets	9.77	7.65	2.99	4.85	6.65	1.71	4.14	5.74
Total Assets	219.59	140.40	156.88	199.65	153.76	51.91	30.38	64.63
Current Liabilities
Accounts Payable	1.59	2.25	4.09	3.38	0.87	1.06	0.63	1.73
Short-Term Debt	1.00	0.34	1.20	1.10	0.99	7.47	5.58	3.69
Current Portion of Long-Term Debt	-	-	-	-	-	7.47	-	-
Accrued Liabilities	8.70	3.49	2.51	10.13	8.78	1.57	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.52
Other Current Liabilities	11.38	6.29	2.51	11.69	8.78	1.57	3.06	0.28
Total Current Liabilities	13.97	8.87	7.80	16.17	10.63	10.10	9.82	8.47
Non-Current Liabilities
Long-Term Debt	8.83	6.30	0.54	1.84	3.05	1.87	9.29	11.06
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	129.87	129.87
Total Non-Current Liabilities	8.83	6.30	0.54	1.84	3.05	1.87	139.16	140.93
Total Liabilities	22.80	15.17	8.34	18.01	13.68	11.97	148.98	149.40
Stockholders' Equity
Common Stock	0.02	0.01	0.01	0.01	0.01	0.01	0.00	2.39
Retained Earnings	-431.17	-364.68	-315.31	-272.81	-233.59	-151.41	-121.91	-87.16
Accumulated Other Comprehensive Income	0.28	0.21	0.04	-0.30	0.00	0.00	0.00	-4.10
Additional Paid-in Capital	627.67	489.69	463.80	454.74	373.66	191.35	3.30	-125.77
Shares Outstanding	178.32	137.82	127.67	126.30	100.83	-	-	-
Total Stockholders' Equity	196.79	125.23	148.54	181.64	140.08	39.95	-118.60	-84.77
Total Liabilities & Equity	219.59	140.40	156.88	199.65	153.76	51.91	30.38	64.63

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Compass Therapeutics Balance Sheet

How much debt does Compass Therapeutics have?

Compass Therapeutics had total debt of $9.83M as of Dec 31, 2025, against $208.91M in cash and short-term investments. Its debt-to-equity ratio was 0.05. Total debt was $6.63M a year earlier.

What are Compass Therapeutics's total assets?

Compass Therapeutics reported total assets of $219.59M as of Dec 31, 2025, up 56.4% from $140.40M a year earlier. Total liabilities were $22.80M.

What is Compass Therapeutics's shareholders' equity?

Compass Therapeutics's shareholders' equity was $196.79M as of Dec 31, 2025, or about $1.10 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition